Arkolith/Insider Trading/ATXS/Form 4

Morabito Christopher

Chief Medical OfficerAstria Therapeutics, Inc. (ATXS) · full profile →Form 4 · filed Apr 3, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$136K
Net Open-Market Flow
-$136K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2024Option exercise(M)10K$3.87$39K10K
Apr 1, 2024Sell(S)10K$13.59$136K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2024Option exercise(M)10K—$080K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-043092) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML